Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPISTOP in infants with tuberous sclerosis complex
2013-005528-40Phase 4Completed
- Sponsor
- Children's Memorial Health Institute
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vigabatrin in epilepsy, epilepsy in tuberous sclerosis complex and tuberous sclerosis complex (TSC) (2 arms), sponsored by Children's Memorial Health Institute. Started Jul 2014; status: completed.
02
Drugs
vigabatrin
03
Conditions
epilepsyepilepsy in tuberous sclerosis complextuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on 2013-005528-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005528-40.